Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status

作者: She-Juan An , Zhi-Hong Chen , Jian Su , Xu-Chao Zhang , Wen-Zhao Zhong

DOI: 10.1371/JOURNAL.PONE.0040109

关键词: MutationCarcinogenesisGeneAdenocarcinomaYoung adultHistologyMedicineImmunologyOncologySurvival analysisLung cancerInternal medicineGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: Background Appropriate patient selection is needed for targeted therapies that are efficacious only in patients with specific genetic alterations. We aimed to define subgroups of patients …

参考文章(32)
M. G. Kris, B. E. Johnson, D. J. Kwiatkowski, A. J. Iafrate, I. I. Wistuba, S. L. Aronson, J. A. Engelman, Y. Shyr, F. R. Khuri, C. M. Rudin, E. B. Garon, W. Pao, J. H. Schiller, E. B. Haura, K. Shirai, G. Giaccone, L. D. Berry, K. Kugler, J. D. Minna, P. A. Bunn, Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC). Journal of Clinical Oncology. ,vol. 29, ,(2011) , 10.1200/JCO.2011.29.15_SUPPL.CRA7506
Akito Hata, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Yukihiro Imai, Yutaka Takahashi, Takashi Nishimura, Keisuke Tomii, Kyosuke Ishihara, Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma Journal of Thoracic Oncology. ,vol. 5, pp. 1197- 1200 ,(2010) , 10.1097/JTO.0B013E3181E2A2BC
Hua-Jun Chen, Tony S. Mok, Zhi-Hong Chen, Ai-Lin Guo, Xu-Chao Zhang, Jian Su, Yi-Long Wu, Clinicopathologic and Molecular Features of Epidermal Growth Factor Receptor T790M Mutation and c-MET Amplification in Tyrosine Kinase Inhibitor-resistant Chinese Non-small Cell Lung Cancer Pathology & Oncology Research. ,vol. 15, pp. 651- 658 ,(2009) , 10.1007/S12253-009-9167-8
Yijun Gao, Gaoxiang Ge, Hongbin Ji, LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor Protein & Cell. ,vol. 2, pp. 99- 107 ,(2011) , 10.1007/S13238-011-1021-6
Kathryn E. Ware, Marianne E. Marshall, Lydia R. Heasley, Lindsay Marek, Trista K. Hinz, Paula Hercule, Barbara A. Helfrich, Robert C. Doebele, Lynn E. Heasley, Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression PLoS ONE. ,vol. 5, pp. e14117- ,(2010) , 10.1371/JOURNAL.PONE.0014117
Giuseppe Bronte, Sergio Rizzo, Laura La Paglia, Vincenzo Adamo, Sergio Siragusa, Corrado Ficorella, Daniele Santini, Viviana Bazan, Giuseppe Colucci, Nicola Gebbia, Antonio Russo, Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma. Cancer Treatment Reviews. ,vol. 36, pp. 21- 29 ,(2010) , 10.1016/S0305-7372(10)70016-5
Chen Mao, Li-Xin Qiu, Ru-Yan Liao, Fang-Bing Du, Hong Ding, Wan-Chun Yang, Jin Li, Qing Chen, None, KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies Lung Cancer. ,vol. 69, pp. 272- 278 ,(2010) , 10.1016/J.LUNGCAN.2009.11.020
Montse Sanchez-Cespedes, The role of LKB1 in lung cancer. Familial Cancer. ,vol. 10, pp. 447- 453 ,(2011) , 10.1007/S10689-011-9443-0
Tsuyoshi Takahashi, Makoto Sonobe, Masashi Kobayashi, Akihiko Yoshizawa, Toshi Menju, Ei Nakayama, Nobuya Mino, Shotaro Iwakiri, Kiyoshi Sato, Ryo Miyahara, Kenichi Okubo, Toshiaki Manabe, Hiroshi Date, Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4 – ALK Fusion Gene Annals of Surgical Oncology. ,vol. 17, pp. 889- 897 ,(2010) , 10.1245/S10434-009-0808-7
Hidefumi Sasaki, Osamu Kawano, Katsuhiko Endo, Eriko Suzuki, Hiroshi Haneda, Haruhiro Yukiue, Yoshihiro Kobayashi, Motoki Yano, Yoshitaka Fujii, Uncommon V599E BRAF mutations in Japanese patients with lung cancer. Journal of Surgical Research. ,vol. 133, pp. 203- 206 ,(2006) , 10.1016/J.JSS.2005.10.022